Sort by
Refine Your Search
-
stabilization team, jointly at the School of Pharmacy and School of Biochemistry and Cell Biology, in University College Cork. The scientist will work within a Horizon-Europe-funded consortium, OptiViVax, where
-
, with expertise in formulating nano-emulsion vaccine adjuvants to join our vaccine stabilization team, jointly at the School of Pharmacy and School of Biochemistry and Cell Biology, in University College
-
; archival, ethnographic, and participatory research; GIS and social network mapping; policy input; socio-economic modelling and analysis; and synthesising quantitative and qualitative data. Achievement
-
translational studies. Our research interests include medical implant design and assessment, medical implant integration, novel drug- and cell-based therapies, soft robotics, immunoengineering, translation of our
-
, Associate Professor in Biomedical Engineering. The researcher will join Dr McEvoy’s group, which brings together expertise in active cell biomechanics and in-vitro tumour models. The group’s overall focus is
-
mechanisms that regulate dopaminergic neuron vulnerability in ageing and Parkinson’s disease, integrating human stem cell–derived neuronal models, in vivo studies and translational human tissue analysis
-
Parkinson’s disease, integrating human stem cell–derived neuronal models, in vivo studies and translational human tissue analysis. The work focuses on how oxidative stress, mitochondrial dysfunction and
-
innovative design for manufacture and assembly, modern methods of construction and design for disassembly construction techniques. MASH will significantly impact on defence forces mobility and responsiveness